# Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage

> **NCT02957305** · PHASE4 · COMPLETED · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 211 (actual)

## Conditions studied

- Miscarriage in First Trimester

## Interventions

- **DRUG:** Misoprostol 400mcg Tab
- **DRUG:** Misoprostol 200mcg Tab

## Key facts

- **NCT ID:** NCT02957305
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-21
- **Primary completion:** 2019-10-19
- **Final completion:** 2020-06-30
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2021-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02957305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02957305, "Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02957305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*